期刊文献+

造血干细胞移植后血流感染的临床分析 被引量:3

Clinical Analysis of Bloodstream Infection after Hematopoietic Stem Cell Transplantation
下载PDF
导出
摘要 目的:分析造血干细胞移植(HSCT)患者血流感染的临床特征。方法:回顾性分析2013年1月至2020年6月在我科行HSCT的910例患者的临床特征、发生血流感染的病原菌分布及药敏情况。结果:910例患者中,111例在移植后100 d内确诊血流感染,98例的血流感染发生在粒细胞缺乏(粒缺)期。多因素分析显示,预处理方案含抗胸腺细胞球蛋白(ATG)、粒缺持续时间长、单个核细胞(MNC)输注量低是HSCT后血流感染的独立危险因素。分离出的121株病原菌中,革兰氏阴性(G^(-))菌76株(62.8%),革兰氏阳性(G^(+))菌40株(33.1%),真菌5株(4.1%)。病原菌前3位依次为大肠埃希菌、表皮葡萄球菌和铜绿假单胞菌。大肠埃希菌、肺炎克雷伯菌和铜绿假单胞菌对碳青霉烯类药物耐药率分别为14.3%、7.7%和66.7%。G^(+)菌对万古霉素、利奈唑胺、替考拉宁的敏感率分别为97.5%、100%和100%。血流感染患者HSCT后100 d死亡率显著高于无血流感染患者(P<0.001)。结论:预处理方案含ATG、粒缺持续时间长、MNC输注量低是HSCT后血流感染的独立危险因素,移植后血流感染病原菌以革兰氏阴性菌多见,铜绿假单胞菌对碳青霉烯类药物耐药率高。 Objective:To analyze the clinical characteristics of bloodstream infection(BSI)in patients treated by hematopoietic stem cell transplantation(HSCT).Methods:The clinical characteristics,distribution of pathogenic bacteria causing BSI and drug sensitivity of 910 patients treated by HSCT in our department from January 2013 to June 2020 were retrospectively analyzed.Results:Among 910 HSCT patients,111 patients were diagnosed as BSI within 100 days after transplantation,and 98 patients showed BSI during the period of agranulocytosis.Multivariate analysis showed that the usage of anti-thymocyte globulin(ATG),long duration of agranulocytosis and low infusion volume of mononuclear cell(MNC)were the independent risk factors affecting BSI after HSCT.Among 121 pathogenic bacteria isolated,76 Gram-negative(G^(-))bacteria(62.8%),40 Gram-positive(G^(+))bacteria(33.0%),and 5 fungi(4.1%)were detected out.The top three pathogens were Escherichia coli,Staphylococcus epidermidis and Pseudomonas aeruginosa.The drug-resistance rates of Escherichia coli and Klebsiella pneumoniae to carbapenems was 14.3%and 7.7%,respectively,and Pseudomonas aeruginosa was 66.7%.The susceptibility of G^(+)bacteria to vancomycin,linezolid and teicoplanin was 97.5%,100%and100%,respectively.The crude mortality rate of the patients with BSI at 100 days after HSCT was significantly higher than that of patients without BSI(P<0.001).Conclusion:The usage of ATG,long duration of agranulocytosis and low infusion volume of MNC are independent risk factors for BSI after HSCT.The pathogens after HSCT are mainly G^(-)bacteria.Pseudomonas aeruginosa is highly resistant to carbapenems.
作者 吴莹莹 刘倍材 刘练金 袁诗思 韦杰敏 王丽淋 王佩锡 刘继聪 赖永榕 李桥川 WU Ying-Ying;LIU Bei-Cai;LIU Lian-Jin;YUAN Shi-Si;WEI Jie-Min;WANG LI-LIN;WANG Pei-Xi;LIU Ji-Cong;LAI Yong-Rong;LI Qiao-Chuan(Department of Hematology,The First Affiliated Hospital of Guangxi Medical University,Nanning 530021,Guangxi Zhuang Autonomous Region,China)
出处 《中国实验血液学杂志》 CAS CSCD 北大核心 2022年第1期292-297,共6页 Journal of Experimental Hematology
基金 国家自然科学基金(81960038)。
关键词 造血干细胞移植 血流感染 耐药性 hematopoietic stem cell transplantation bloodstream infection drug-resistance
  • 相关文献

参考文献5

二级参考文献48

  • 1汪复.2005中国CHINET细菌耐药性监测结果[J].中国感染与化疗杂志,2006,6(5):289-295. 被引量:284
  • 2黄晓军.造血干细胞移植感染诊治策略[J].中华医学杂志,2006,86(42):2953-2956. 被引量:12
  • 3段明辉,周道斌,王书杰,韩冰,赵永强,沈悌.自体外周血干细胞移植术后早期感染的分析[J].中华内科杂志,2007,46(1):32-34. 被引量:3
  • 4Kersun LS, Propert K J, Lautenbach E, et al. Early bacteremia in pediatric hematopoietic stem cell transplant patients on oral antibiotic prophylaxis. Pediatr Blood Cancer, 2005, 45 : 162-169.
  • 5Almyroudis NG, Fuller A, Jakubowski A, et al. Pre- and post- engraftment bloodstream infection rates and associated mortality in allogeneic hematopoietic stem cell transplant recipients. Transpl Infect Dis, 2005,7:11-17.
  • 6Sparrelid E, Higglund H, Remberger M, et al. Bacteraemia during the aplastic phase after allogeneic bone marrow transplantation is associated with early death from invasive fungal infection. Bone Marrow Transplant, 1998, 22 : 795-800.
  • 7Ortega M, Rovira M, Almela M, et al. Bacterial and fungal bloodstream isolates from 796 hematopoietic stem cell transplant recipients between 1991 and 2000. Ann Hematol, 2005, 84: 40- 46.
  • 8Jun HX, Zhixiang S, Chun W, et al. Clinical guidelines for the management of cancer patients with neutropenia and unexplained fever. Int J Antimicrob Agents, 2005, 26 Supl 2 :S128-132.
  • 9Weaver CH, Schwartzberg LS, Hainsworth J, et al. Treatment- related mortality in 1000 consecutive patients receiving high-dose chemotherapy and peripheral blood progenitor cell transplantation in community cancer centers. Bone Marrow Transplant, 1997, 19 : 671-678.
  • 10Marttn-Pefia A, Aguilar-Guisado M, Espigado I, et al. Prospective study of infectious complications in allogeneic hematopoietic stem cell transplant recipients [ J/OL ]. Clin Transplant, 2010. http ://onlinelibrary. wiley, com/doi/10.1111/ j. 1399-0012. 2010. 01286. x/abstract. [ Epub ahead of print].

共引文献6124

同被引文献23

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部